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An asymptomatic 37-year-old woman with good oral
hygiene received plain radiographs (Figure 1) as part ofa wisdom teeth extraction preoperative work-up. Unenhanced
computed tomography (CT) with multiplanar and 3-dimen-
sional reformations (Figures 2 and 3) was performed to follow
up the findings on radiography.Figure 1. (A) Waters/occipitomental view. Enlargement of the left greater wing of the sphenoid, zygomatic arch, and facial asymmetry (white arrows).
Diminutive maxillary sinus (arrowheads). Mandibular findings are seen faintly (black arrows). (B) Pantomograph. Expansile lytic lesion centered in the left
mandibular angle without associated periosteal reaction or cortical breakthrough (black arrows). Left sphenoid expansion (arrowheads) is also seen. There is
superior displacement of the inferior alveolar canal in the left mandible (grey arrows).
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Figure 2. Axial and coronal reformatted nonenhanced CT images (1.25-mm bone algorithm and bone window). (A) Axial image showing bony expansion and
ground-glass matrix involving the left zygomatic and sphenoid bones with narrowing of the vidian canal (black arrows). (B) Axial image showing bony
expansion and ground-glass matrix involving the left zygomatic and sphenoid bones with narrowing of the foramen rotundum (white arrows). (C) Coronal
reformatted image showing bony expansion and ground-glass matrix involving the left zygomatic and sphenoid bones with narrowing and displacement of the
vidian canal (black arrow) and the foramen rotundum (white arrow).
214 C. M. Theoret et al. / Canadian Association of Radiologists Journal 60 (2009) 213e216Diagnosis
Leontiasis ossea (polyostotic facial fibrous dysplasia).
Radiologic Findings
Radiographs and CT images demonstrate the expansile
nature of the process involving the facial bones and
mandible. There is narrowing of the vidian canal and
foramen rotundum. There is no evidence of soft tissue mass,
periosteal reaction, or cortical breakthrough.
Figure 3. Three-dimensional reformatted volume-rendering image with
surface shade display built from 1.25-mm standard algorithm images. Note
the facial asymmetry with enlargement of the left lateral orbital wall and
zygomatic bone. Streak artifact is secondary to the patient’s dental fillings.Discussion
Fibrous dysplasia (FD) is a genetic, noninherited benign
bone lesion. It can present at any age, but usually is detected
by the third decade of life [1]. FD constitutes 5% to 7% of
benign bone tumours and has no sex predilection [1].
FD may occur in several forms. Monostotic FD is the
most common form and affects a single bone, usually the
ribs, femur, tibia, cranium, maxilla, or mandible. Monostotic
lesions enlarge in proportion to skeletal growth [1]. Poly-
ostotic FD involves several sites, usually is isolated to one
side of the body, and often involves facial bones. Lesions of
polyostotic FD often continue to enlarge after skeletal
maturity is achieved [1]. Leontiasis ossea is the term given to
FD with maxillary involvement that results in a progressive
protrusion of the malar surface and loss of the nasomaxillary
angle, resulting in a leonine facial appearance [2]. Another
form of FD occurs as part of the classic triad of the McCune-
Albright syndrome: FD with precocious puberty and cafe´-
au-lait cutaneous pigment changes [1]. Mazabraud syndrome
is the combination of FD and intramuscular myxomas [1].
On a molecular level, FD is the result of an amino acid
substitution mutation of cysteine or histidine for arginine at
position 210 in chromosome 20 [1]. This substitution
mutation in some somatic cells results in increased intra-
cellular messengers that stimulate cellular proliferation and
inappropriate differentiation [1]. Subsequent abnormal
development and mineralization of bone can result in loss of
strength in the affected bone [1].
Clinically, affected individuals may have variable
presentations, depending on the location of the lesion.
Patients with craniofacial FD may be asymptomatic or
present with bony or neuropathic pain, swelling or deformity,
or cranial neuropathies [1,3,4].
FD often first is identified on plain radiographs. Its
appearance usually is described as ground-glass and it may
have one or a combination of the following patterns: pagetoid,
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pattern. Lesions increase the diameter of the involved bone,
with a smooth periosteum and a scalloped endosteal margin.
Other features include reactive bone formation and loss of
distinction between the cortex and medulla. Uncomplicated
FD lesions typically look nonaggressive [5].
Craniofacial FD usually is unilateral, but may cross suture
lines. It expands the diploic space and displaces the outer
table, sparing the inner table. The main radiographic diag-
nostic considerations for craniofacial FD are neo-osteo-
genesis near a site of surgery or chronic inflammation,
ossifying fibroma, osteoma [6], or Paget’s disease [1]. Other
lesions that may present clinically as slowly progressive
swelling in the face are neurofibromas, hemangiomas, and
lymphatic or vascular malformations [2]. Cherubism shows
bilateral maxillary and/or mandibular expansion, but is
histologically separate from fibrous dysplasia [7].
CT in craniofacial FD exquisitely shows the classic
ground-glass matrix and bone expansion with intact cortex,
and also can show potential complications such as optic
nerve compression and neural foraminal stenosis. Multi-
planar reformation may be useful to assess neural foraminal
involvement. As in this case, 3-dimensional reformations can
be used to illustrate the bony expansion and overall
appearance. If iodinated contrast is given, variable
enhancement of the fibrous component may be seen [6].
Magnetic resonance imaging may be helpful in the eval-
uation of a FD lesion, particularly in the assessment of
adjacent soft tissue in craniofacial lesions. However, given
the variable composition of FD lesions, signal intensity can
vary [8]. On T1, FD has low or intermediate signal owing to
the mineralized stroma, high fibrous tissue content, and low
water content [1,5]. The mineralized component also
provides low T2 signal and the metabolically active fibrous
components and cystic spaces yield high T2 signal intensity.
Therefore, lesions on T2-weighted images may have a range
of appearances depending on the ratio of mineralized to
fibrous material in the lesion. The enhancement can be
variable, with the fibrous component often enhancing
intensely [6]. Small central vessels and larger peripheral
sinusoids account for the enhancement of these lesions [5,8].
Unfortunately, the magnetic resonance image appearance is
nonspecific because intermediate T1 intensity and high T2
intensity are features common to both fibrous dysplasia and
sinister entities including malignancy [5].
Nuclear medicine scintigraphic imaging is important in the
initial work-up of a patient with suspected FD to rule out
polyostotic disease. By using technetium-99m, FD lesions
may show increased, minimal, or no uptake, depending on the
metabolic activity of the lesion [9]. On a 3-phase scan, the
uptake is most pronounced in the delayed phase [9]. In addition
to Tc-99 m methylene diphosphonate (MDP) uptake, FD
lesions have been found to show gallium-67 uptake [10].
Complications of fibrous dysplasia depend on the location
of the lesion. Bony pain, deformities, and pathologic or
fatigue fractures may involve any bone. Involvement of the
cranium and facial bones can produce a wide range ofcomplications including headaches, anosmia, deafness,
visual loss, diplopia, recurrent otitis, malocclusion, and
trigeminal neuralgia. Lesions may hemorrhage spontane-
ously or result in sinus obstruction and mucocele formation
[11,12]. Nearly half of patients with FD of the temporal bone
develop external ear canal cholesteatoma [4].
A rare but serious complication of FD is malignant
transformation. The rate of malignant transformation is
quoted as between less than 1% and 5% in the literature
[3,13]. A history of radiotherapy may be associated with
malignant degeneration [3]. Clinical findings that suggest the
possibility of malignant transformation include a rapid
increase in pain and size of a lesion, intralesional necrosis,
bleeding, and increased serum alkaline phosphatase level [3].
The most common malignancies are osteosarcoma, fibro-
sarcoma, and chondrosarcoma [13].
If a case of FD is noted incidentally on an imaging study,
it usually is suggested that the patient undergo a bone scan to
rule out polyostotic disease. Instead of proceeding to biopsy,
it is suggested that the patient undergo follow-up evaluation
and observation every 6 months for an unspecified amount of
time [1]. Ophthalmic and cranial nerve examinations are
necessary to detect neurologic deficits early in FD of the
craniofacial bones. Ippolito et al [14] suggested that patients
with FD undergo endocrinologic evaluation to optimize
medical management. If the diagnosis is unsure, a test of
peripheral blood may allow detection of the genetic mutation
associated with fibrous dysplasia.
If surgery is deemed necessary, it has been suggested that
it be delayed until skeletal maturity is reached because of the
risk of recurrence with subsequent growth [1]. Simple
curettage and osteotomies show recurrence and heal with
dysplastic bone [1]. Reconstruction with autologous cancel-
lous bone graft may be successful in some cases [1]. The
utility of bisphosphonate therapy in fibrous dysplasia has
been studied with early reports suggesting possible benefits
of pain control, decreased bone turnover, and improved
radiologic appearance [15].
There is controversy regarding treatment of craniofacial
FD. Vision loss, one of the most serious complications of
craniofacial FD, can progress rapidly and become irrevers-
ible. It has been hypothesized that this vision loss is
secondary to invasion of the optic canal by dysplastic bone.
Some groups advocate prophylactic decompression of the
optic nerve, based on CT findings of encroachment of the
optic canal [3]. However, in a retrospective review, Michael
et al [16] found that visual loss in 20 cases of FD may not
have been prevented by prophylactic optic canal decom-
pression, leading the investigators to offer alternate theories
of visual loss including displacement or distortion of the
globe with traction on the optic nerve, external compression
by a cystic lesion, and vascular events.
Although craniofacial FD is typically a benign disease, it
can have serious complications, predominantly relating to
regional mass effect and nerve compression. Knowledge of
this entity and its typical appearance can facilitate early
diagnosis. Beyond diagnosis, close radiologic evaluation for
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direct treatment.
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